Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liver disease; and FibroView data management software. It provides digital health management services; compound turtle shell softening liver tablets; and prescription drugs. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.
Metrics to compare | 300049 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300049PeersSector | |
|---|---|---|---|---|
P/E Ratio | 98.8x | 20.6x | −0.5x | |
PEG Ratio | 2.83 | 0.06 | 0.00 | |
Price/Book | 7.7x | 2.5x | 2.6x | |
Price / LTM Sales | 9.5x | 3.7x | 3.2x | |
Upside (Analyst Target) | - | 26.2% | 44.7% | |
Fair Value Upside | Unlock | 3.3% | 5.7% | Unlock |